OTCMKTS:NWCI - Newcardio Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $0.0055 0.00 (0.00 %) (As of 07/19/2018 07:50 AM ET)Previous Close$0.0056Today's Range$0.0025 - $0.005552-Week Range$0.0006 - $0.0140Volume10,500 shsAverage Volume18,427 shsMarket Capitalization$180,000.00P/E RatioN/ADividend YieldN/ABeta5.88 Company ProfileEarnings HistoryHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. Receive NWCI News and Ratings via Email Sign-up to receive the latest news and ratings for NWCI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolOTCMKTS:NWCI CUSIPN/A Webwww.newcardio.com Phone510-774-1969 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares33,150,000Market Cap$0.18 Newcardio (OTCMKTS:NWCI) Frequently Asked Questions What is Newcardio's stock symbol? Newcardio trades on the OTCMKTS under the ticker symbol "NWCI." What is the consensus analysts' recommendation for Newcardio? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Newcardio in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Newcardio's key competitors? Some companies that are related to Newcardio include Guided Therapeutics (GTHP), SpectraScience (SCIE), IMRIS (IMRSQ), Echo Therapeutics (ECTE), Magna-Lab (MAGAA) and Electrocore (ECOR). Who are Newcardio's key executives? Newcardio's management team includes the folowing people: Dr. Jess Emery Jones M.D., Chief Exec. Officer and Director (Age 39)Mr. Greg Sadowski, Chief Operating OfficerMr. Gilbert V. Molina, Director of Corp. SystemsDr. Gari Clifford Ph.D., Technology Advisor Has Newcardio been receiving favorable news coverage? News stories about NWCI stock have trended somewhat positive recently, according to Accern. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Newcardio earned a news sentiment score of 0.23 on Accern's scale. They also gave media headlines about the company an impact score of 46.33 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. How do I buy shares of Newcardio? Shares of NWCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Newcardio's stock price today? One share of NWCI stock can currently be purchased for approximately $0.0055. How big of a company is Newcardio? Newcardio has a market capitalization of $180,000.00. How can I contact Newcardio? Newcardio's mailing address is 2350 MISSION COLLEGE BLVD. #1175, SANTA CLARA CA, 95054. The company can be reached via phone at 510-774-1969 or via email at [email protected] MarketBeat Community Rating for Newcardio (OTCMKTS NWCI)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 11 (Vote Outperform)Underperform Votes: 16 (Vote Underperform)Total Votes: 27MarketBeat's community ratings are surveys of what our community members think about Newcardio and other stocks. Vote "Outperform" if you believe NWCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: What are CEFs?